The FDA issued a go-ahead for SpinTech’s SPIN-SWI software, a processing tool to enhance quantification and detection of key neurovascular biomarkers in magnetic resonance images.

The software applies proprietary post-processing techniques to enhance the visualization of small blood vessels in the brain to assess clinical data provided by MR scanners.

The technology can process and evaluate images for conditions such as Parkinson’s disease, stroke, traumatic brain injury and vascular dementia.